Shingles Vaccine
50 years old or older
Zostavax
Provider:
MSD
Certification:
FDA & EMA & Hong Kong Department of Health
Suggested age:
50 years old or older
Disease Prevention:
Although almost all persons develop lifelong immunity after chickenpox infection, the virus may remain latent in the body and recur many years later as herpes zoster (shingles).
Side Effect:
Soreness, redness and swelling where the vaccine was given.
Interval:
1 dose (Subcutaneous injection)

Precautions:
-
Disease Prevention: Although almost all persons develop lifelong immunity after chickenpox infection, the virus may remain latent in the body and recur many years later as herpes zoster (shingles).